They intraperitoneally injected anti-CTLA-4 or anti-CD28, respectively, and found that, compared with the anti-CD28-treated or untreated control mice, anti-CTLA-4 treated mice showed inhibited B7-51BLimlO tumor growth. This evidence concerns the gene CTLA4 and neoplasm.